Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001932552 | SCV002137357 | uncertain significance | not provided | 2021-03-21 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals with ACTN4-related conditions. This variant is present in population databases (rs750429771, ExAC 0.01%). This sequence change replaces aspartic acid with asparagine at codon 804 of the ACTN4 protein (p.Asp804Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. |
Fulgent Genetics, |
RCV002478163 | SCV002783360 | uncertain significance | Focal segmental glomerulosclerosis 1 | 2022-02-11 | criteria provided, single submitter | clinical testing |